Tudóstér: Földi-Bíró Linda publikációi

Bíró, L., Tóth, B., Lihi, N., Farkas, E., Buglyó, P.: Interaction between [(eta(6)-p-cym)M(H2O)(3)](2+) (M-II = Ru, Os) or [(eta(5)-Cp*)M(H2O)(3)](2+) (M-III = Rh, Ir) and Phosphonate Derivatives of Iminodiacetic Acid: A Solution Equilibrium and DFT Study.
Molecules. 28 (3), 1-17-, 2023.

Bíró, L., Buglyó, P., Farkas, E.: Diversity in the Interaction of Amino Acid- and Peptide-Based Hydroxamic Acids with Some Platinum Group Metals in Solution.
Molecules. 27 (3), 1-27, 2022.

Bíró, L., Ozsváth, A., Kapitány, R., Buglyó, P.: Pd(II) Binding Strength of a Novel Ambidentate Dipeptide-Hydroxypyridinonate Ligand: A Solution Equilibrium Study.
Molecules. 27 (14), 1-13, 2022.

Bíró, L., Buglyó, P., Farkas, E.: Factors Determining the Metal Ion Binding Ability and Selectivity of Hydroxamate-Based Compounds.
Curr. Med. Chem. 28 (35), 7209-7237, 2021.

Nagy, I., Ferenczik, G., Bíró, L., Farkas, E., Bényei, A., Buglyó, P.: Metal complexation of deferasirox derivatives: A solid state and equilibrium study.
Polyhedron. 190 1-13, 2020.

Ozsváth, A., Bíró, L., Nagy, E., Buglyó, P., Sanna, D., Farkas, E.: Trends and Exceptions in the Interaction of Hydroxamic Acid Derivatives of Common Di- and Tripeptides with Some 3d and 4d Metal Ions in Aqueous Solution.
Molecules. 24 (21), 1-25, 2019.

Sanna, D., Ugone, V., Micera, G., Buglyó, P., Bíró, L., Garribba, E.: Speciation in human blood of Metvan, a vanadium based potential anti-tumor drug.
Dalton Trans. 46 (28), 8950-8967, 2017.

Buglyó, P., Parajdi-Losonczi, P., Bényei, A., Lihi, N., Bíró, L., Farkas, E.: Versatility of Coordination Modes in Complexes of Monohydroxamic Acids with Half-Sandwich Type Ruthenium, Rhodium, Osmium and Iridium Cations.
ChemistrySelect. 2 (26), 8127-8136, 2017.

Sanna, D., Serra, M., Ugone, V., Manca, L., Pirastru, M., Buglyó, P., Bíró, L., Micera, G., Garribba, E.: Biorelevant reactions of the potential anti-tumor agent vanadocene dichloride.
Metallomics. 8 (5), 532-541, 2016.

Sanna, D., Fabbri, D., Serra, M., Buglyó, P., Bíró, L., Ugone, V., Micera, G., Garribba, E.: Characterization and biotransformation in the plasma and red blood cells of VIVO2+ complexes formed by ceftriaxone.
J. Inorg. Biochem. 147 71-84, 2015.

Patalenszki, J., Bíró, L., Bényei, A., Radosova Muchova, T., Kasparkova, J., Buglyó, P.: Half-sandwich complexes of ruthenium, osmium, rhodium and iridium with DL-methionine or S-methyl-L-cysteine: a solid state and solution equilibrium study.
RSC Adv. 5 (11), 8094-8107, 2015.

Buglyó, P., Bíró, L., Nagy, I., Szőcs, B., Farkas, E.: Hydroxypyronate, thiohydroxypyronate and hydroxypyridinonate derivatives as potential Pb2+ sequestering agents.
Polyhedron. 92 7-11, 2015.

Hüse, D., Bíró, L., Patalenszki, J., Bényei, A., Buglyó, P.: Complex Formation between [(eta(6)-p-cymene)Ru(H2O)(3)](2+) and Hydroxycarboxylates or their Sulfur Analogues - The Role of Thiolate Groups in Metal Ion Binding.
Eur. J. Inorg. Chem. 2014 (30), 5204-5216, 2014.

Bíró, L., Mikó, D., Buglyó, P.: Interaction of [(eta5-Cp*)Ir(H2O)3]2+ with (O,O) Donor Ligands of Biological Importance in Aqueous Solution.
J. Biol. Inorg. Chem. 19 (Suppl), S516, 2014.

Buglyó, P., Bíró, L., Hüse, D., Patalenszki, J., Rohács, L., Szőnyi, S., Bényei, A.: Interaction of [(eta 6-p-cym)M(H2O)3]2+(M = Ru, Os) with Hydroxycarboxylic Acids and Their Sulphur Analogues: A Solution Equilibrium and Solid State Study.
J. Biol. Inorg. Chem. 19 (S1), S514, 2014.

Bíró, L., Balogh, E., Buglyó, P.: Interaction between [Ru([eta]6-p-cym)(H2O)3]2+ and dl-serine or dl-isoserine: The role of the side chain alcoholic OH group in metal ion binding.
J. Organomet. Chem. 734 61-68, 2013.

Bíró, L., Godó, A., Bihari, Z., Garribba, E., Buglyó, P.: Tuning the Hydrolytic Properties of Half-Sandwich-Type Organometallic Cations in Aqueous Solution.
Eur. J. Inorg. Chem. 2013 (17), 3090-3100, 2013.

Sanna, D., Bíró, L., Buglyó, P., Micera, G., Garribba, E.: Biotransformation of BMOV in the presence of blood serum proteins.
Metallomics. 4 (1), 33-36, 2012.

Sanna, D., Buglyó, P., Bíró, L., Micera, G., Garribba, E.: Coordinating Properties of Pyrone and Pyridinone Derivatives, Tropolone and Catechol toward the VO2+ Ion: An Experimental and Computational Approach.
Eur. J. Inorg. Chem. 2012 (7), 1079-1092, 2012.

Bíró, L., Farkas, E., Buglyó, P.: Hydrolytic behaviour and chloride ion binding capability of [Ru(n6-p-cym)(H2O)3]2+: a solution equilibrium study.
Dalton Trans. 41 (1), 285-291, 2012.

Bíró, L., Hüse, D., Bényei, A., Buglyó, P.: Interaction of [Ru([eta]6-p-cym)(H2O)3]2+ with citrate and tricarballate ions in aqueous solution; X-ray crystal structure of novel half-sandwich Ru(II)-citrato complexes.
J. Inorg. Biochem. 116 116-125, 2012.

Griffith, D., Bíró, L., Platts, J., Müller-Bunz, H., Farkas, E., Buglyó, P.: Synthesis and solution behaviour of stable mono-, di- and trinuclear Pd(II) complexes of 2,5-pyridinedihydroxamic acid: X-ray crystal structure of a novel Pd(II) hydroxamato complex.
Inorg. Chim. Acta. 380 291-300, 2012.

Sanna, D., Bíró, L., Buglyó, P., Micera, G., Garribba, E.: Transport of the anti-diabetic VO2+ complexes formed by pyrone derivatives in the blood serum.
J. Inorg. Biochem. 115 87-99, 2012.

Bíró, L., Farkas, E., Buglyó, P.: Complex formation between Ru(eta(6)-p-cym)(H2O)(3) (2+) and (O,O) donor ligands with biological relevance in aqueous solution.
Dalton Trans. 39 (42), 10272-10278, 2010.